Armistice Capital, LLC Portage Biotech Inc. Transaction History

Armistice Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.21 - $0.55 $34,462 - $90,257	-164,105 Reduced 9.85%	1,501,780 $315,000
Q1 2024 May 15, 2024	SELL	$0.41 - $1.89 $86,190 - $397,315	-210,220 Reduced 11.21%	1,665,885 $932,000
Q4 2023 Feb 13, 2024	SELL	$1.09 - $2.65 $100,280 - $243,800	-92,000 Reduced 4.67%	1,876,105 $3.41 Million
Q3 2023 Nov 14, 2023	BUY	$2.09 - $3.68 $4.11 Million - $7.24 Million	1,968,105 New	1,968,105 $4.11 Million

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $65.4M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.